Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Argentina Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20151
20171
20181
20191
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company3
Intellia Therapeutics1
Novo Nordisk A/S1
Pfizer1
Shire1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn8
Musculoskeletal Diseases4
Achondroplasia3
Bone Diseases3
Metabolic Diseases3
Metabolism, Inborn Errors3
Mucopolysaccharidosis IV3
Osteochondrodysplasias3
Brain Diseases2
Brain Diseases, Metabolic, Inborn2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.